Document is current
Any future updates will be listed below
-
Authors
Hassan, Nozhat T.
Van Treeck, Briana
RodrÃguez-Vargas, Anthony
Sheppard, Anna E.
Collins, Kathleen
Adelson, David L.
-
Funding
Funding for this research was provided by:
Fulbright Future Scholarship
National Institutes of Health (F32 GM139306)
National Institutes of Health (DP1 HL156819)
California Institute for Regenerative Medicine (EDUC4-1279)
- License Information
-
More Information
Article History
Received: 19 May 2025
Accepted: 6 April 2026
First Online: 14 April 2026
Declarations
:
: Not applicable.
: K.C. is a co-founder, Board member, and consultant to Addition Therapeutics, Inc., reviewed and approved by the University of California, Berkeley in accordance with its conflict of interest policies. K.C. and B.V.T. are listed inventors on patent applications filed by the University of California, Berkeley related to the PRINT platform.
